168 related articles for article (PubMed ID: 8182151)
1. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.
Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
J Clin Invest; 1994 May; 93(5):2197-205. PubMed ID: 8182151
[TBL] [Abstract][Full Text] [Related]
2. Role of activation of ectosolic 5'-nucleotidase in the cardioprotection mediated by opening of K+c channels.
Kitakaze M; Minamino T; Node K; Komamura K; Shinozaki Y; Chujo M; Mori H; Inoue M; Hori M; Kamada T
Am J Physiol; 1996 May; 270(5 Pt 2):H1744-56. PubMed ID: 8928882
[TBL] [Abstract][Full Text] [Related]
3. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release.
Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
Circulation; 1994 Mar; 89(3):1237-46. PubMed ID: 8124812
[TBL] [Abstract][Full Text] [Related]
4. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase.
Kitakaze M; Node K; Minamino T; Komamura K; Funaya H; Shinozaki Y; Chujo M; Mori H; Inoue M; Hori M; Kamada T
Circulation; 1996 Feb; 93(4):781-91. PubMed ID: 8641008
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary administration of the alpha 1-receptor agonist, methoxamine, does not reproduce the infarct-limiting effect of ischemic preconditioning in dogs.
Sebbag L; Katsuragawa M; Verbinski S; Jennings RB; Reimer KA
Cardiovasc Res; 1996 Nov; 32(5):830-8. PubMed ID: 8944813
[TBL] [Abstract][Full Text] [Related]
6. Role of intracellular Ca2+ in activation of protein kinase C during ischemic preconditioning.
Node K; Kitakaze M; Sato H; Minamino T; Komamura K; Shinozaki Y; Mori H; Hori M
Circulation; 1997 Aug; 96(4):1257-65. PubMed ID: 9286957
[TBL] [Abstract][Full Text] [Related]
7. Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart.
Komamura K; Kitakaze M; Funaya H; Ueda Y; Node K; Minamino T; Kurihara T; Hori M
J Cardiovasc Pharmacol; 1997 Dec; 30(6):775-83. PubMed ID: 9436817
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity.
Minamino T; Kitakaze M; Morioka T; Node K; Komamura K; Takeda H; Inoue M; Hori M; Kamada T
Am J Physiol; 1996 Jan; 270(1 Pt 2):H238-44. PubMed ID: 8769757
[TBL] [Abstract][Full Text] [Related]
9. Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage.
Kitakaze M; Hori M; Takashima S; Sato H; Inoue M; Kamada T
Circulation; 1993 Jan; 87(1):208-15. PubMed ID: 8419009
[TBL] [Abstract][Full Text] [Related]
10. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo.
Iliodromitis EK; Tasouli A; Andreadou I; Bofilis E; Zoga A; Cokkinos P; Kremastinos DT
Eur J Pharmacol; 2004 Sep; 499(1-2):163-9. PubMed ID: 15363963
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Adenosine Formation by Ecto-5'-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning.
Wolff G; Truse R; Decking U
PLoS One; 2015; 10(8):e0135086. PubMed ID: 26261991
[TBL] [Abstract][Full Text] [Related]
13. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA).
Zhao L; Kirsch CC; Hagen SR; Elliott GT
J Mol Cell Cardiol; 1996 Jan; 28(1):197-208. PubMed ID: 8745227
[TBL] [Abstract][Full Text] [Related]
14. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
Schwartz LM; Sebbag L; Jennings RB; Reimer KA
J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
[TBL] [Abstract][Full Text] [Related]
15. alpha1-Adrenoceptors during simulated ischemia and reoxygenation of the human myocardium: effect of the dose and time of administration.
Loubani M; Galiñanes M
J Thorac Cardiovasc Surg; 2001 Jul; 122(1):103-12. PubMed ID: 11436042
[TBL] [Abstract][Full Text] [Related]
16. The possible role of adrenergic component in ischemic preconditioning.
Sharma A; Singh M
Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):493-9. PubMed ID: 9413833
[TBL] [Abstract][Full Text] [Related]
17. Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts.
Diaz RJ; Wilson GJ
J Mol Cell Cardiol; 1997 Jan; 29(1):129-39. PubMed ID: 9040028
[TBL] [Abstract][Full Text] [Related]
18. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
Vander Heide RS; Reimer KA
Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
[TBL] [Abstract][Full Text] [Related]
19. The effect of xenon anesthesia on the size of experimental myocardial infarction.
Baumert JH; Hein M; Gerets C; Baltus T; Hecker KE; Rossaint R
Anesth Analg; 2007 Nov; 105(5):1200-6, table of contents. PubMed ID: 17959941
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
